Clinical Trial

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center, randomized, double-blind, placebo/active-controlled study. 405 subjects undergoing orthopedic surgery under general anesthesia are planned to be enrolled and randomized into the HSK21542 group, morphine group, and placebo group.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Trial Details
NCT Number NCT07186426
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Postoperative Pain Management
Enrollment 405 participants
Start Date 2025-07-28
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13